Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study.

Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study. J Clin Oncol. 2001 Feb 15; 19(4):1021-9.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Bone Marrow
Cisplatin
Doxorubicin
Drug Administration Schedule
Endometrial Neoplasms
Feasibility Studies
Female
Genital Neoplasms, Female
Granulocyte Colony-Stimulating Factor
Heart
Humans
Male
Middle Aged
Paclitaxel
Peripheral Nerves

authors with profiles

Gini Fleming